Company developments, acquisitions, partnerships and market information about healthcare robotics companies.
19 article(s) from the past 14 days
Curabotics has entered into a national contract with Capstone Health Alliance, a group purchasing organization, to bring robotics and automation solutions to hundreds of member hospitals across the US. This partnership expands access to Curabotics' hospital robotics and automation technology through the health alliance's procurement network.
Medical Center Enterprise in the United States has announced a $3 million investment for a surgical robot. The investment aims to expand the hospital's surgical capabilities with robot-assisted technology.
Distalmotion, the Swiss developer of the Dexter surgical robotic system, has secured a term loan of up to USD 70 million. The funding is intended to support the further commercialization and deployment of their robotic surgical platform. Distalmotion is based in the Geneva-Bern region and focuses on minimally invasive robotic surgery.
Swiss surgical robotics company Distalmotion has secured a debt facility of up to $70 million to support its push into the US market with its Dexter surgical robot system. Dexter is designed to assist minimally invasive laparoscopic procedures. The funding will be used to accelerate commercialization and expand the company's presence in the United States.
Distalmotion has closed a financing round of up to $70 million with Perceptive Advisors to support the expansion of its robotic surgical system into U.S. ambulatory surgery centers (ASCs). Distalmotion is the developer of the Dexter robotic surgery platform. The funding is intended to accelerate commercial growth in the U.S. market.
Stryker has announced the acquisition of CMR Surgical for approximately $400 million, marking its entry into soft-tissue surgical robotics. CMR Surgical is the maker of the Versius robotic surgical system, which is used in Europe and other regions for minimally invasive procedures. The deal expands Stryker's robotics portfolio beyond its existing orthopedic focus.
Stryker has announced a $400 million investment in CMR Surgical, the UK-based maker of the Versius surgical robotic system, with an option for full acquisition. CMR Surgical is a prominent European player in the minimally invasive surgical robotics market. This deal could have significant implications for the competitive landscape of surgical robotics in Europe.
Stryker has signed a partnership deal with UK-based CMR Surgical to advance robotic-assisted surgery. CMR Surgical develops the Versius surgical robotic system, which is already deployed in multiple European hospitals. The collaboration aims to expand access to and adoption of robotic surgery solutions.
Stryker is backing CMR Surgical, the British maker of the Versius surgical robot system, with a $400 million investment deal. This move signals strong strategic interest from major medtech players in the surgical robotics market. CMR Surgical is a European company whose Versius system is already deployed in multiple European hospitals.
Stryker has announced a $400 million investment in CMR Surgical, the UK-based developer of the Versius surgical robotic system, with an option for full acquisition. CMR Surgical is a key European player in the minimally invasive surgical robotics market. This deal could have significant implications for the landscape of surgical robotics in Europe.
Stryker has committed £300 million to CMR Surgical, a Cambridge-based surgical robotics company. This significant investment highlights continued major industry interest in surgical robotics platforms. CMR Surgical develops the Versius robotic surgical system, which is deployed in hospitals across Europe and beyond.
Stryker has made a $400 million bet on robotic surgery, signaling a major strategic investment in the surgical robotics space. This move highlights the continued expansion of large medical device companies into robot-assisted surgical systems.
Ukrainian healthcare network Dobrobut has purchased a Da Vinci robotic surgery system and plans to establish a dedicated robotic surgery center. This represents one of the first robotic-assisted surgery initiatives in Ukraine. The deployment marks an expansion of surgical robotics into Eastern Europe.
Stryker is investing $400 million in CMR Surgical, the UK-based maker of the Versius soft tissue surgical robot used in minimally invasive procedures. This move marks Stryker's entry into soft tissue robotics, complementing its existing Mako orthopedic robot platform. CMR Surgical has deployed its system in hospitals across Europe and globally.
A Toronto-based robotics startup is working to expand options for surgical procedures. The company is developing robotic systems targeting the surgical market, aiming to broaden the range of available operative interventions. No further details on specific systems or clinical outcomes are available from the description alone.
Stryker and CMR Surgical have announced a strategic alliance aimed at advancing robotic-assisted surgery. CMR Surgical is the UK-based manufacturer of the Versius surgical robotic system, which is already deployed in European hospitals. The partnership is intended to accelerate the development and broader adoption of surgical robotics.
Stryker is investing $400 million in CMR Surgical, the UK-based developer of the Versius surgical robotic system. As part of the deal, Stryker gains U.S. sales rights for the Versius platform and an option to fully acquire CMR Surgical in the future. This represents a major strategic move for both companies in the competitive surgical robotics market.
Stryker and CMR Surgical have announced a strategic alliance aimed at advancing robotic-assisted surgery. CMR Surgical, the British maker of the Versius surgical robotic system, is already active across multiple European hospital sites. The partnership is intended to strengthen both companies' positions in the surgical robotics market.
Stryker has invested approximately $400 million in CMR Surgical, the British developer of the Versius surgical robotic system, and has secured an option to acquire the company at a later stage. This significant investment strengthens Stryker's foothold in the surgical robotics market. CMR Surgical is a European company with growing clinical deployment of its Versius robot across hospitals in Europe and beyond.